COMMUNIQUÉS West-GlobeNewswire

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib
17/04/2026
Data from subset analysis of cabozantinib-pretreated patients support potential to overcome resistance and resensitize tumors to VEGF TKI therapy 44% ORR and 94% DCR in ccRCC patients previously treated with [...]
Vistin Pharma ASA: Invitation to Q1 2026 conference call
17/04/2026
Oslo, Norway, 17 April 2026 Vistin Pharma ASA (VISTN) will release its first quarter results on Friday 24th of April 2026. Vistin Pharma will host a conference call for all shareholders and interested parties on the [...]
New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles
17/04/2026
Report outlines 17 targeted actions to address structural barriers hindering leadership progression COPENHAGEN, Denmark and OSLO, Norway and STOCKHOLM, April 17, 2026 (GLOBE NEWSWIRE) -- The Nordic life science sector [...]
Immuron Double Digit 3Q Sales Growth
17/04/2026
Sales Highlights (unaudited): Global Q3 sales AUD$1.5 million up 16% on prior comparative period (pcp) YTD Mar 2026 sales AUD$5.7 million up 7% on prior comparative period (pcp) Australia Q3 sales AUD$0.9 million up 15 [...]
CARBIOS présente ses résultats annuels 2025
17/04/2026
Carbios a fortement réduit ses charges opérationnelles au cours de l’année 2025, permettant une réduction de la perte d’exploitation de 7 millions d’euros Carbios dispose d’une trésorerie solide à hauteur de 59 millions [...]
Carbios announces fiscal-year 2025 financial results
17/04/2026
Carbios significantly reduced its operating expenses during 2025, resulting in a €7 million reduction in operating loss Carbios has a solid cash position of €59 million as of December 31, 2025, on a Group basis [...]
Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage
17/04/2026
Three world-leading key opinion leaders, researchers and clinicians, join Clinical Advisory Board, reinforcing Bioxodes’ global registrational clinical strategy Positive ongoing discussions with regulators on pivotal [...]
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
17/04/2026
NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
Kailera Therapeutics Announces Pricing of Initial Public Offering
17/04/2026
WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced [...]
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
17/04/2026
Enters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“ [...]
OsteoShield Claims Evaluated: Premium-Quality Bone Density Support Formula by Peak Health Research
16/04/2026
A Peak Health Research informational report on OsteoShield's bone density support formulation, Aquamin marine mineral complex, Palm-Collagen blend, zombie cell inflammation research context, ingredient dosage [...]
Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto
17/04/2026
Picard to showcase the SynCardia TAH and next-generation innovation TUCSON, Ariz., April 16, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of [...]
TerrAscend Appoints Eric Jackson as Chief Financial Officer
16/04/2026
TORONTO, April 16, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis operator, today announced the appointment of Eric Jackson as [...]
VapoFil Under Investigation: Evaluating the Vapor Rub Male Enhancement Honey Trick Claims
16/04/2026
A 2026 informational overview of VapoFil ingredients, the viral Vapor Rub male enhancement honey trick trend, supplement label transparency, dosing research context, and what men should know before buying Largo, FL, [...]
Extendicare Announces Voting Results for its 2026 Annual Meeting of Shareholders
17/04/2026
MARKHAM, Ontario, April 16, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual meeting of shareholders held on April 16, [...]
JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
17/04/2026
WESTFIELD, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- JATT II Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the [...]
Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems
16/04/2026
AI-driven command and control platform applied in real-world railway operations, supporting broader infrastructure and security use cases NETANYA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: [...]
Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year
16/04/2026
Sanuwave is pleased to announce preliminary revenues of $9.6 million to $9.7 million for the first quarter ended March 31, 2026, in line with prior guidance for Q1. EDEN PRAIRIE, Minn., April 16, 2026 (GLOBE NEWSWIRE [...]
Globus Medical Schedules First Quarter Earnings Release and Conference Call
16/04/2026
AUDUBON, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2026 after the [...]

Pages